Keating, M., Kim, T. M., Awan, F., Cai, J., Uppala, A., Chaudhry, A., Mohamed, H., Namuduri, M., Walewski, J. (2025). Odronextamab treatment for patients with rare subtypes of relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL): Updated efficacy and safety analyses from a dedicated cohort of the ELM-2 study. Blood. https://doi.org/10.1182/blood-2025-5523